HC Wainwright & Co. Maintains Neutral on Versus Systems, Raises Price Target to $2

HC Wainwright & Co. analyst Scott Buck maintains Versus Systems (NASDAQ:VS) with a Neutral and raises the price target from $1.5 to $2.

HC Wainwright & Co. analyst Scott Buck maintains Versus Systems (NASDAQ:VS) with a Neutral and raises the price target from $1.5 to $2.

Total
0
Shares
Related Posts
Read More

Edgewise Therapeutics Announces Journal Of Clinical Investigation Publication Of Key Preclinical Data Linking Modulation Of Fast Skeletal Muscle Contraction To Protection Of Skeletal Muscle In Models Of Duchenne Muscular Dystrophy

- Data provide key insights supporting Edgewise's strategy to advance EDG-5506 for the treatment of Duchenne and Becker muscular dystrophy - Edgewise Therapeutics, Inc., (NASDAQ:EWTX), a clinical-stage

EWTX